1. Home
  2. FHB vs DYN Comparison

FHB vs DYN Comparison

Compare FHB & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Hawaiian Inc.

FHB

First Hawaiian Inc.

N/A

Current Price

$24.80

Market Cap

3.4B

Sector

Finance

ML Signal

N/A

DYN

Dyne Therapeutics Inc.

N/A

Current Price

$17.21

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FHB
DYN
Founded
1858
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.8B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
FHB
DYN
Price
$24.80
$17.21
Analyst Decision
Hold
Strong Buy
Analyst Count
11
17
Target Price
$28.89
★ $34.33
AVG Volume (30 Days)
★ 2.5M
2.4M
Earning Date
10-23-2026
11-05-2026
Dividend Yield
★ 4.22%
N/A
EPS Growth
★ 22.91
N/A
EPS
★ 1.67
N/A
Revenue
★ $880,788,000.00
N/A
Revenue This Year
$6.32
N/A
Revenue Next Year
$56.09
N/A
P/E Ratio
$14.78
★ N/A
Revenue Growth
★ 8.94
N/A
52 Week Low
$23.26
$14.00
52 Week High
$30.58
$27.31

Technical Indicators

Market Signals
Indicator
FHB
DYN
Relative Strength Index (RSI) 44.40 49.96
Support Level $24.19 $16.65
Resistance Level $25.42 $17.31
Average True Range (ATR) 0.48 0.96
MACD -0.07 0.11
Stochastic Oscillator 15.31 47.09

Price Performance

Historical Comparison
FHB
DYN

About FHB First Hawaiian Inc.

First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: